Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
<p>Abstract</p> <p>Background</p> <p>Clusterin is a cytoprotective chaperone protein involved in numerous physiological processes, carcinogenesis, tumor growth and tissue remodelling. The purpose of this study was to investigate whether clusterin (CLU), an antiapoptotic...
Main Authors: | Hassan Mohamed K, Watari Hidemichi, Han Yimin, Mitamura Takashi, Hosaka Masayoshi, Wang Lei, Tanaka Shinya, Sakuragi Noriaki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://www.jeccr.com/content/30/1/113 |
Similar Items
-
Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
by: Dong Choon Park, et al.
Published: (2008-09-01) -
Clusterin Expression in Colorectal Carcinomas
by: Teresa Téllez, et al.
Published: (2023-09-01) -
Clusterin and Psoriasis; What is the Relation?
by: Osama Hashem, et al.
Published: (2020-01-01) -
The role of Clusterin in cancer metastasis
by: Peng M, et al.
Published: (2019-03-01) -
The association of serum clusterin levels and Clusterin rs11136000 polymorphisms with Alzheimer disease in a Turkish cohort
by: Gamze Guven, et al.
Published: (2020-01-01)